Abstract
Aortobifemoral bypass (ABF) has long been the gold standard for treatment of aortoiliac occlusive disease, proving to be a durable procedure with a 10 year patency rate of 80–90 % in more recent reports. Peri-operative mortality of 1–3 % can be achieved.
Endovascular treatment of aortoiliac lesions has evolved rapidly over the past two decades. Long segment stenosis and occlusion are now increasingly being treated with endovascular therapy, reflecting significant changes in practice patterns since the publication of the Trans-Atlantic Inter-Society Consensus Group (TASC) Guidelines in 2007.
Contemporary results demonstrate that compared to ABF, endovascular therapy has a lower primary patency rate, but similar secondary patency and limb salvage up to 5, and perhaps even 10, years after the index procedure.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Chiesa R, Marone EM, Tshomba Y, Logaldo D, Castellano R, Melissano G. Aortobifemoral bypass grafting using expanded polytetrafluoroethylene stretch grafts in patients with occlusive atherosclerotic disease. Ann Vasc Surg. 2009;23:764–9.
Hertzer NR, Bena JF, Karafa MT. A personal experience with direct reconstruction and extra-anatomic bypass for aortoiliofemoral occlusive disease. J Vasc Surg. 2007;45:527–35; discussion 35.
Onohara T, Komori K, Kume M, et al. Multivariate analysis of long-term results after an axillobifemoral and aortobifemoral bypass in patients with aortoiliac occlusive disease. J Cardiovasc Surg (Torino). 2000;41:905–10.
Reed AB, Conte MS, Donaldson MC, Mannick JA, Whittemore AD, Belkin M. The impact of patient age and aortic size on the results of aortobifemoral bypass grafting. J Vasc Surg. 2003;37:1219–25.
Faries PL, LoGerfo FW, Hook SC, et al. The impact of diabetes on arterial reconstructions for multilevel arterial occlusive disease. Am J Surg. 2001;181:251–5.
Norgren L, Hiatt WR, Dormandy JA, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(Suppl S):S5–67.
Chiu KW, Davies RS, Nightingale PG, Bradbury AW, Adam DJ. Review of direct anatomical open surgical management of atherosclerotic aorto-iliac occlusive disease. Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg. 2010;39:460–71.
Dimick JB, Cowan Jr JA, Henke PK, et al. Hospital volume-related differences in aorto-bifemoral bypass operative mortality in the United States. J Vasc Surg. 2003;37:970–5.
de Vries SO, Hunink MG. Results of aortic bifurcation grafts for aortoiliac occlusive disease: a meta-analysis. J Vasc Surg. 1997;26:558–69.
Back MR, Johnson BL, Shames ML, Bandyk DF. Evolving complexity of open aortofemoral reconstruction done for occlusive disease in the endovascular era. Ann Vasc Surg. 2003;17:596–603.
Dua A, Upchurch Jr GR, Lee JT, Eidt J, Desai SS. Predicted shortfall in open aneurysm experience for vascular surgery trainees. J Vasc Surg. 2014;60:945–9.
Jongkind V, Akkersdijk GJ, Yeung KK, Wisselink W. A systematic review of endovascular treatment of extensive aortoiliac occlusive disease. J Vasc Surg. 2010;52:1376–83.
Danczyk RC, Mitchell EL, Burk C, et al. Comparing patient outcomes between multiple ipsilateral iliac artery stents and isolated iliac artery stents. J Vasc Surg. 2012;55:1637–46 e5; Discussion 46.
Ye W, Liu CW, Ricco JB, Mani K, Zeng R, Jiang J. Early and late outcomes of percutaneous treatment of TransAtlantic Inter-Society Consensus class C and D aorto-iliac lesions. J Vasc Surg. 2011;53:1728–37.
Kashyap VS, Pavkov ML, Bena JF, et al. The management of severe aortoiliac occlusive disease: endovascular therapy rivals open reconstruction. J Vasc Surg. 2008;48:1451–7, 7 e1-3.
Kudo T, Chandra FA, Ahn SS. Long-term outcomes and predictors of iliac angioplasty with selective stenting. J Vasc Surg. 2005;42:466–75.
Zannetti S, L’Italien GJ, Cambria RP. Functional outcome after surgical treatment for intermittent claudication. J Vasc Surg. 1996;24:65–73.
Nackman GB, Banavage A, Graham AM. Predictors of health after operation for aortoiliac occlusive and aneurysmal disease. Surgery. 2001;130:370–7.
Klein WM, van der Graaf Y, Seegers J, et al. Dutch iliac stent trial: long-term results in patients randomized for primary or selective stent placement. Radiology. 2006;238:734–44.
Sixt S, Alawied AK, Rastan A, et al. Acute and long-term outcome of endovascular therapy for aortoiliac occlusive lesions stratified according to the TASC classification: a single-center experience. J Endovasc Ther Off J Int Soc Endovasc Spec. 2008;15:408–16.
Ichihashi S, Higashiura W, Itoh H, Sakaguchi S, Nishimine K, Kichikawa K. Long-term outcomes for systematic primary stent placement in complex iliac artery occlusive disease classified according to Trans-Atlantic Inter-Society Consensus (TASC)-II. J Vasc Surg. 2011;53:992–9.
Bosiers M, Deloose K, Callaert J, et al. BRAVISSIMO: 12-month results from a large scale prospective trial. J Cardiovasc Surg (Torino). 2013;54:235–53.
Pulli R, Dorigo W, Fargion A, et al. Early and long-term comparison of endovascular treatment of iliac artery occlusions and stenosis. J Vasc Surg. 2011;53:92–8.
Piazza M, Ricotta 2nd JJ, Bower TC, et al. Iliac artery stenting combined with open femoral endarterectomy is as effective as open surgical reconstruction for severe iliac and common femoral occlusive disease. J Vasc Surg. 2011;54:402–11.
AbuRahma AF, Hayes JD, Flaherty SK, Peery W. Primary iliac stenting versus transluminal angioplasty with selective stenting. J Vasc Surg. 2007;46:965–70.
Koizumi A, Kumakura H, Kanai H, et al. Ten-year patency and factors causing restenosis after endovascular treatment of iliac artery lesions. Circ J Off J Japanese Circ Soc. 2009;73:860–6.
Mwipatayi BP, Thomas S, Wong J, et al. A comparison of covered vs bare expandable stents for the treatment of aortoiliac occlusive disease. J Vasc Surg. 2011;54:1561–70.
Humphries MD, Armstrong E, Laird J, Paz J, Pevec W. Outcomes of covered versus bare-metal balloon-expandable stents for aortoiliac occlusive disease. J Vasc Surg. 2014;60:337–43.
Chang RW, Goodney PP, Baek JH, Nolan BW, Rzucidlo EM, Powell RJ. Long-term results of combined common femoral endarterectomy and iliac stenting/stent grafting for occlusive disease. J Vasc Surg. 2008;48:362–7.
Bekken JA, Vos JA, Aarts RA, de Vries JP, Fioole B. DISCOVER: Dutch Iliac Stent trial: COVERed balloon-expandable versus uncovered balloon-expandable stents in the common iliac artery: study protocol for a randomized controlled trial. Trials. 2012;13:215.
Fakhry F, Rouwet EV, den Hoed PT, Hunink MG, Spronk S. Long-term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial. Br J Surg. 2013;100:1164–71.
Murphy TP, Cutlip DE, Regensteiner JG, et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation. 2012;125:130–9.
Schurmann K, Mahnken A, Meyer J, et al. Long-term results 10 years after iliac arterial stent placement. Radiology. 2002;224:731–8.
Scali ST, Schmit BM, Feezor RJ, et al. Outcomes after redo aortobifemoral bypass for aortoiliac occlusive disease. J Vasc Surg. 2014;60:346–55 e1.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Hong, M.S., Pevec, W.C. (2017). In Patients with Aortoiliac Occlusive Disease, Does Endovascular Repair Improve Outcomes When Compared to Open Repair?. In: Skelly, C., Milner, R. (eds) Difficult Decisions in Vascular Surgery. Difficult Decisions in Surgery: An Evidence-Based Approach. Springer, Cham. https://doi.org/10.1007/978-3-319-33293-2_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-33293-2_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-33291-8
Online ISBN: 978-3-319-33293-2
eBook Packages: MedicineMedicine (R0)